PLAY PODCASTS
NCI: How to bet on Uranium & Nuclear Renaissance w/ Paul Mann, CEO ASP Isotopes
Episode 30

NCI: How to bet on Uranium & Nuclear Renaissance w/ Paul Mann, CEO ASP Isotopes

In this episode of Non Consensus Investing, Ram Ahluwalia, CIO at Lumida Wealth, interviews Paul Mann, Chairman and CEO of ASP Isotopes. They discuss the company's unique isotope enrichment technologies, which offer significant advancements for industries such as semiconductors, healthcare, and nuclear energy. The conversation covers ASP Isotopes' innovative approaches, including aerodynamic separation and quantum laser enrichment, and the growing demand for enriched isotopes amidst geopolitical and supply chain challenges. Mann also shares insights into ASP Isotopes' strategic plans, future growth potential, and the company's journey from its inception to becoming a key player in the isotope industry. Disclaimer: ASP Isotopes is a listed company. Please review the disclaimers published in their 10-K and 10-Q filings with the SEC. This video is for informational purposes only and does not constitute investment advice. Always conduct your own research and consult with a financial advisor before making any investment decisions.

Lumida Wealth : Non-Consensus Invest Beyond the Ordinary

June 27, 20241h 8m

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

00:00 Introduction to Non Consensus Investing

00:31 Meet Paul Mann: Chairman and CEO of ASP

01:42 The Importance of Silicon 28 in Semiconductors

07:11 Geopolitical and Technological Aspects of Isotope Enrichment

13:53 Challenges and Innovations in Uranium Supply

22:53 Exploring HALU and Quantum Enrichment

28:09 Medical Applications and Isotope Opportunities

32:37 Business Potential and Market Dynamics

36:20 Discussing Margins and Business Strategy

37:53 Technical Feasibility and Readiness

39:06 Investment and Plant Operations

41:42 Customer Contracts and Capital Investment

45:32 Company Background and Founding Story

52:25 Building the Team and Overcoming Challenges

54:02 Public Markets and Financing Strategy

59:31 Future Plans and Market Position

01:06:06 Conclusion and Final Thoughts

Connect with Us Online:

Lumida News

Lumida Deals

Lumida Wealth

Lumida ETF

 

Watch the video on Youtube: https://www.youtube.com/@Lumida_Wealth

🌐 Website: https://www.lumidawealth.com

🐦 Twitter Follow us on https://twitter.com/LumidaWealth

🎵 TikTok: https://www.tiktok.com/@lumidawealth

📸 Instagram: https://www.instagram.com/lumidawealth

📘 Facebook: https://www.facebook.com/lumidawealth

 

Topics

enriched uranium marketbusiness opportunities in isotopesenriched silicon benefitsnfc and nasdaq listed companiesinterviewsilicon 28 isotopesemiconductor trendsasp isotopesalternative investmentsisotope-based pharmaceuticalsisotope enrichment technologyasp aerodynamic separation processuranium supply chainhigh assay low enriched uranium (halu)molybdenum 100 isotopehigh net worth clientsinnovative enrichment technologypaul mannlumida wealthasp quantum enrichment technologyquantum computing materialsmedical isotopescarbon 14 applicationsnuclear energy renaissanceradioactive trace elements in medicineisotope enrichment plant operationsenergy efficiency in semiconductorsgeopolitical impacts on semiconductorsnon consensus investingsmall modular reactors (smrs)